Brief: Enveric Biosciences To Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
23/02/2024 13:42
Feb 23 (Reuters) - Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES AGREES TO SELL CANCER-TARGETING
CANNABINOID-RELATED INTELLECTUAL PROPERTY
* ENVERIC BIOSCIENCES INC - AGREED TO SELL ONE OF ITS
CANCER-RELATED PATENT PORTFOLIOS FOR AN UNDISCLOSED AMOUNT
* ENVERIC BIOSCIENCES INC: PLANS TO CONTINUE TO FOCUS AND
INVEST
IN DEVELOPMENT OF ITS LEAD CANDIDATES EB-003
* ENVERIC BIOSCIENCES INC: PLANS TO CONTINUE TO FOCUS AND
INVEST
IN DEVELOPMENT OF ITS LEAD CANDIDATES EB-002, FORMERLY EB-373
Source text for Eikon: ID:nBw3vZZKca
Further company coverage: ENVB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003